With the introduction of new therapies for asthma like biologics, achieving disease remission has become a new goal of treatment and classifying asthma control is in transition. In December 2023, the Annals of Allergy, Asthma & Immunology published a consensus statement between the American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society to update the definition of clinical remission in asthma. In this webinar, learn more about the consensus statement and the outcomes of the working group.
Speaker:
Michael S. Blaiss, MD
Clinical Professor of Pediatrics
Medical College of Georgia at Augusta University
Augusta, Georgia
Michael S. Blaiss, MD, is a clinical professor of pediatrics at Medical College of Georgia in Augusta, Georgia, and allergist at Good Samaritan Health Center of Gwinnett in Norcross, Georgia. He received his medical degree from the University of Tennessee Center for Health Sciences and did pediatrics at University of Tennessee/Le Bonheur Children’s Medical Center in Memphis and completed a fellowship in allergy/immunology at Ochsner Medical Foundation in New Orleans, Louisiana.
He is past president of the American College of Allergy, Asthma and Immunology. He served as treasurer of the American Board of Allergy and Clinical Immunology, a past member of the Board of Directors of the World Allergy Organization and past president of the Tennessee and Louisiana Societies of Allergy, Asthma and Immunology. He was Executive Medical Director of the American College of Allergy, Asthma, and Immunology. Dr. Blaiss has published about 200 scientific peer-reviewed articles and presented at more than 500 meetings and seminars throughout the world.
This Advances webinar is in partnership with the American College of Allergy, Asthma & Immunology. ACAAI offers CMEs for physicians for this webinar. If you are a member of ACAAI, you can obtain CME through the member portal for Advances webinars.
All attendees will be offered a certificate of attendance. No other continuing education credit is provided.